Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients

Clinical Immunology

Volumn 129, Issue 3, 2008, Pages 428-437

  Cai, Lun ^a,b   Zhang, Zheng ^b   Zhou, Lin ^d   Wang, Haiyan ^c   Fu, Junliang ^b   Zhang, Shuye ^b   Shi, Min ^b   Zhang, Hui ^b   Yang, Yongping ^b   Wu, Hao ^c   Tien, Po ^a   Wang, Fu Sheng ^b  

^a INSTITUTE OF MICROBIOLOGY   (China)

^b BEIJING 302 HOSPITAL   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d NONE

Author keywords

Hepatocellular carcinoma; Liver; ; NK cells; ; Regulatory T cells;

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; GAMMA INTERFERON;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL STRAIN K 562; CONTROLLED STUDY; FEMALE; FUNCTIONAL DISEASE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; LIVER; LIVER CELL CARCINOMA; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE;

ANTIGENS, CD56; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; HUMANS; INTERFERON-GAMMA; K562 CELLS; KILLER CELLS, NATURAL; LIVER; LIVER NEOPLASMS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; RECEPTORS, IGG; T-LYMPHOCYTES, REGULATORY;

EID: 55249097842     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.08.012     Document Type: Article

References (32)

1. Llovet J.M., Burroughs A., and Bruix J. Hepatocellular carcinoma. Lancet 362 (2003) 1907-1917
2. Kawasaki A., Shinkai Y., Yagita H., and Okumura K. Expression of perforin in murine natural killer cells and cytotoxic T lymphocytes in vivo. Eur. J. Immunol. 22 (1992) 1215-1219
3. Cooper M.A., and Caligiuri M.A. Isolation and characterization of human natural killer cell subsets. Curr. Protoc. Immunol. Chapter 7 (2004) Unit 7-34
4. Subleski J.J., Hall V.L., Back T.C., Ortaldo J.R., and Wiltrout R.H. Enhanced antitumor response by divergent modulation of natural killer and natural killer T cells in the liver. Cancer Res. 66 (2006) 11005-11012
5. Bai X., Wang S., Tomiyama-Miyaji C., Shen J., Taniguchi T., Izumi N., Li C., Bakir H.Y., Nagura T., Takahashi S., Kawamura T., Iiai T., Okamoto H., Hatakeyama K., and Abo T. Transient appearance of hepatic natural killer cells with high cytotoxicity and unique phenotype in very young mice. Scan. J. Immunol. 63 (2006) 275-281
6. Vermijlen D., Seynaeve C., Luo D., Kruhoffer M., Eizirik D.L., Orntoft T.F., and Wisse E. High-density oligonucleotide array analysis reveals extensive differences between freshly isolated blood and hepatic natural killer cells. Eur. J. Immunol. 34 (2004) 2529-2540
7. Jarahian M., Watzl C., Issa Y., Altevogt P., and Momburg F. Blockade of natural killer cell-mediated lysis by NCAM140 expressed on tumor cells. Int. J. Cancer 120 (2007) 2625-2634
8. Cao W., Xi X., Hao Z., Li W., Kong Y., Cui L., Ma C., Ba D., and He W. RAET1E2, a soluble isoform of the UL16-binding protein RAET1E produced by tumor cells, inhibits NKG2D-mediated NK cytotoxicity. J. Biol. Chem. 282 (2007) 18922-18928
9. Kano Y., Soda K., Nakamura T., Saitoh M., Kawakami M., and Konishi F. Increased blood spermine levels decrease the cytotoxic activity of lymphokine-activated killer cells: a novel mechanism of cancer evasion. Cancer Immunol. Immunother. 56 (2007) 771-781
10. Jovic V., Konjevic G., Radulovic S., Jelic S., and Spuzic I. Impaired perforin-dependent NK cell cytotoxicity and proliferative activity of peripheral blood T cells is associated with metastatic melanoma. Tumori. 87 (2001) 324-329
11. Pross H.F., and Lotzova E. Role of natural killer cells in cancer. Nat. Immunol. 12 (1993) 279-292
12. Steinhauer E.H., Doyle A.T., Reed J., and Kadish A.S. Defective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease. J. Immunol. 129 (1982) 2255-2259
13. Ishiyama K., Ohdan H., Ohira M., Mitsuta H., Arihiro K., and Asahara T. Difference in cytotoxicity against hepatocellular carcinoma between liver periphery natural killer cells in humans. Hepatology 43 (2006) 362-372
14. Sung M.W., Johnson J.T., Van Dongen G., and Whiteside T.L. Protective effects of interferon-gamma on squamous-cell carcinoma of head and neck targets in antibody-dependent cellular cytotoxicity mediated by human natural killer cells. Int. J. Cancer 66 (1996) 393-399
15. Fu J., Xu D., Liu Z., Shi M., Zhao P., Fu B., Zhang Z., Yang H., Zhang H., Zhou C., Yao J., Jin L., Wang H., Yang Y., Fu Y.X., and Wang F.S. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 132 (2007) 2328-2339
16. Ghiringhelli F., Menard C., Terme M., Flament C., Taieb J., Chaput N., Puig P.E., Novault S., Escudier B., Vivier E., Lecesne A., Robert C., Blay J.Y., Bernard J., Caillat-Zucman S., Freitas A., Tursz T., Wagner-Ballon O., Capron C., Vainchencker W., Martin F., and Zitvogel L. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. J. Exp. Med. 202 (2005) 1075-1085
17. Smyth M.J., Teng M.W., Swann J., Kyparissoudis K., Godfrey D.I., and Hayakawa Y. CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer. J. Immunol. 176 (2006) 1582-1587
18. Trzonkowski P., Szmit E., Mysliwska J., Dobyszuk A., and Mysliwski A. CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction. Clin. Immunol. 112 (2004) 258-267
19. Sheng Z.W., Wu F.S., Ma Z.M., Feng Y.Z., Zhou X.R., and Teng L.S. The Chinese classification system compared with TNM staging in prognosis of patients with primary hepatic carcinoma after resection. Hepatobiliary Pancreat. Dis. Int. 4 (2001) 561-564
20. Xu D., Fu J., Jin L., Zhang H., Zhou C., Zou Z., Zhao J.M., Zhang B., Shi M., Ding X., Tang Z., Fu Y.X., and Wang F.S. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J. Immunol. 177 (2006) 739-747
21. Lecoeur H., Fevrier M., Garcia S., Riviere Y., and Gougeon M.L. A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity. J. Immunol. Methods 253 (2001) 177-187
22. Zhang Z., Zhang J.Y., Wherry E.J., Jin B., Xu B., Zou Z.S., Zhang S.Y., Li B.S., Wang H.F., Wu H., Lau G.K., Fu Y.X., and Wang F.S. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B. Gastroenterology 134 (2008) 1938-1949
23. Alter G., Malenfant J.M., and Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods 294 (2004) 15-22
24. Balch C.M., Tilden A.B., Dougherty P.A., Cloud G.A., and Abo T. Heterogeneity of natural killer lymphocyte abnormalities in colon cancer patients. Surgery 95 (1984) 63-70
25. Gazit R., Aker M., Elboim M., Achdout H., Katz G., Wolf D.G., Katzav S., and Mandelboim O. NK cytotoxicity mediated by CD16 but not by NKp30 is functional in Griscelli syndrome. Blood 109 (2007) 4306-4312
26. Mandelboim O., Malik P., Davis D.M., Jo C.H., Boyson J.E., and Strominger J.L. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 5640-5644
27. Schleypen J.S., Baur N., Kammerer R., Nelson P.J., Rohrmann K., Grone E.F., Hohenfellner M., Haferkamp A., Pohla H., Schendel D.J., Falk C.S., and Noessner E. Cytotoxic markers and frequency predict functional capacity of natural killer cells infiltrating renal cell carcinoma. Clin. Cancer Res. 12 (2006) 718-725
28. Koga T., Harada H., Shi T.S., Okada S., Suico M.A., Shuto T., and Kai H. Hyperthermia suppresses the cytotoxicity of NK cells via down-regulation of perforin/granzyme B expression. Biochem. Biophys. Res. Commun. 337 (2005) 1319-1323
29. Hayakawa Y., Kelly J.M., Westwood J.A., Darcy P.K., Diefenbach A., Raulet D., and Smyth M.J. Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin. J. Immunol. 169 (2002) 5377-5381
30. Screpanti V., Wallin R.P., Ljunggren H.G., and Grandien A. A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells. J. Immunol. 167 (2001) 2068-2073
31. Smyth M.J., Thia K.Y., Cretney E., Kelly J.M., Snook M.B., Forbes C.A., and Scalzo A.A. Perforin is a major contributor to NK cell control of tumor metastasis. J. Immunol. 162 (1999) 6658-6662
32. Terme M., Chaput N., Combadiere B., Ma A., Ohteki T., and Zitvogel L. Regulatory T cells control dendritic cell/NK cell cross-talk in lymph nodes at the steady state by inhibiting CD4+ self-reactive T cells. J. Immunol. 180 (2008) 4679-4686